Cumberland Pharmaceuticals CPIX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's total costs & expenses?
- Cumberland Pharmaceuticals (CPIX) reported total costs & expenses of $12.26M in Q1 2026.
- How has Cumberland Pharmaceuticals's total costs & expenses changed year-over-year?
- Cumberland Pharmaceuticals's total costs & expenses increased by 17.7% year-over-year, from $10.42M to $12.26M.
- What is the long-term trend for Cumberland Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's total costs & expenses has grown at a 2.0% compound annual growth rate (CAGR), from $43.66M to $47.31M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company during a reporting period, including cost of goods sold, research and development, and administrative overhead. It serves as a comprehensive measure of the total resources consumed to support business operations and revenue generation. Monitoring this figure allows investors to evaluate the company's overall cost structure and operational efficiency relative to its top-line performance.